Unigen announces settlement in patent infringement case
July 30th 2007Leiner admitted the validity of the Unigen patents and agreed not to sell any products containing the ingredients Scutellaria and Acacia catechu while the Unigen patents are in force, unless it were to receive a license to do so from Unigen.
Drugmakers submit substandard data for analysis, study finds
July 23rd 2007The opportunity for drug companies to voluntarily compare their new drugs with relevant treatment alternatives occurs only 17% of the time, according a study that examined how closely information submitted to formulary committees at managed healthcare systems and PBMs complies with national guidelines from AMCP.